
Ashland Inc.
ASH
Updated: 24/09/2026, 09:26:17
Ashland Inc. operates as a global supplier of specialized chemicals and additives. Its business activities are structured into four main divisions: Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents. The Life Sciences segment delivers pharmaceutical formulations, encompassing controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and binding agents for tablets. It also offers nutritional compounds like thickeners, stabilizers, emulsifiers, and various additives, alongside nutraceutical items designed for weight management, joint comfort, gastrointestinal health, sports nutrition, and general well-being. Additionally, this division provides custom formulation services, toll processing, and particle engineering expertise. The Personal Care & Household division manufactures a diverse array of naturally derived, biodegradable, and high-performance ingredients for personal care products. Its offerings extend to solutions for oral hygiene, such as toothpastes, mouthwashes, denture cleansers, and general dental care. For household applications, it supplies nature-sourced rheology modifiers, biodegradable wetting agents for surfaces, advanced encapsulants, and specialized polymers. The Specialty Additives segment's portfolio includes rheology modifiers, agents for foam control, surfactants, wetting agents, pH neutralizers, and advanced ceramic materials, which find application in catalytic converters, environmental filters, components for ceramic capacitors, plasma display panels, and solar cells. Furthermore, it supplies ingredients for textile printing, thermoplastic metals, and alloys utilized in welding processes. The Intermediates and Solvents division is responsible for producing 1,4 butanediol and its associated derivatives, notably n-methylpyrrolidone. Ashland's diverse product portfolio serves clientele across numerous consumer and industrial sectors, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceuticals. The company, previously known as Ashland Global Holdings Inc., was established in Wilmington, Delaware, in 1924.
No summaries found.
- Share price
- $69.01
- Market cap
- $3.16B
- Exchange
- NYSE
- Currency
- USD
- CEO
- Guillermo Novo
- Employees
- 2,900
- IPO date
- 17/03/1980
- Beta
- 0.391
- Last dividend
- $0.00
- Day range
- $68.52 – $70.04
- 52-week range
- $46.30 – $78.25
- 1-day performance
- -0.93%
- 1-year performance
- 49.05%
- Current drawdown (1Y)
- -11.81%
- CIK
- 0001674862
- CUSIP
- 044186104
- ISIN
- US0441861046
- Created
- 07/12/2025, 02:10:06
- Last update
- 24/09/2026, 09:26:17
Track Ashland Inc. with an AI analyst
See which prediction-market events move ASH, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Activist Investor Pressure Mounts for a Competitive Sale of Ashland Inc. (NYSE: ASH)
Market Data • Market Data • 11/06/2026, 20:00:23
Ashland responds to investor presentation by Ancora Alternatives LLC
GlobeNewsWire • STOCK • 10/06/2026, 20:07:00
Why Is Ashland (ASH) Up 16.6% Since Last Earnings Report?
Zacks Investment Research • STOCK • 28/05/2026, 14:31:33
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ashland Inc. - ASH
PRNewsWire • STOCK • 21/05/2026, 17:45:00
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ashland Inc. - ASH
GlobeNewsWire • STOCK • 19/05/2026, 19:37:00
Ashland Board appoints Bertrand Loy as new director
GlobeNewsWire • STOCK • 18/05/2026, 09:00:00
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ashland Inc. - ASH
PRNewsWire • STOCK • 15/05/2026, 01:01:00
Ashland board authorizes quarterly dividend
GlobeNewsWire • STOCK • 05/05/2026, 19:01:00
ASH Q2 Earnings and Sales Miss on Weak Pricing, Intermediates Weakness
Zacks Investment Research • STOCK • 04/05/2026, 11:20:15
Ashland Inc. (ASH) Q2 2026 Earnings Call Transcript
Seeking Alpha • STOCK • 29/04/2026, 18:51:46
Ashland (ASH) Reports Q2 Earnings: What Key Metrics Have to Say
Zacks Investment Research • STOCK • 28/04/2026, 23:01:09
Ashland (ASH) Q2 Earnings and Revenues Miss Estimates
Zacks Investment Research • STOCK • 28/04/2026, 22:01:42